These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2555851

  • 21. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR, Jackson B.
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [Abstract] [Full Text] [Related]

  • 22. Potassium depletion enhances renal compensatory hypertrophy in the nephrectomized rat.
    Peterson LN, Carpenter B, Guttierrez GA, Fajardo C, Levine DZ.
    Miner Electrolyte Metab; 1987 Jun; 13(1):57-62. PubMed ID: 2438547
    [Abstract] [Full Text] [Related]

  • 23. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Jun; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 24. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 25. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E.
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [Abstract] [Full Text] [Related]

  • 26. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M, Hess P, Nuesslein-Hildesheim B, Bruneval P, Clozel JP.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
    [Abstract] [Full Text] [Related]

  • 27. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-Khansari M, Ghobadi G, Shakiba B.
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [Abstract] [Full Text] [Related]

  • 28. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P.
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [Abstract] [Full Text] [Related]

  • 29. Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats.
    Lee SK, Jin SY, Han DC, Hwang SD, Lee HB.
    Nephrol Dial Transplant; 1993 Dec; 8(12):1338-43. PubMed ID: 8159302
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 31. Effect of captopril on the progression of induced pyelonephritis in the rat.
    Hall RL, Wilke WL, Fettman MJ.
    Am J Vet Res; 1986 May; 47(5):1085-8. PubMed ID: 3521405
    [Abstract] [Full Text] [Related]

  • 32. The effect of enalapril and sairei-to on survival-time for the rat with subtotal nephrectomy.
    Satoh S, Kaneko T, Omori S, Sugimura J, Ujiie T, Fujioka T, Kubo T.
    Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):112-8. PubMed ID: 7752502
    [Abstract] [Full Text] [Related]

  • 33. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G.
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [Abstract] [Full Text] [Related]

  • 34. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet.
    Kanno Y, Suzuki H, Okada H, Saruta T.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):480-4. PubMed ID: 7515994
    [Abstract] [Full Text] [Related]

  • 35. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX, Song T, Zhou SH, Liu YH, Wu SJ, Liu LY.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):368-75. PubMed ID: 18334254
    [Abstract] [Full Text] [Related]

  • 36. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 28; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 37. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    Jarusiripipat C, Chan L, Shapiro JI, Schrier RW.
    J Pharmacol Exp Ther; 1992 Jan 28; 260(1):243-7. PubMed ID: 1731040
    [Abstract] [Full Text] [Related]

  • 38. Azotemia during chronic converting enzyme inhibition with enalapril in sodium-depleted rats: role of renal circulatory changes.
    Mento PF, Wilkes BM.
    J Cardiovasc Pharmacol; 1986 Jan 28; 8(4):670-5. PubMed ID: 2427802
    [Abstract] [Full Text] [Related]

  • 39. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
    Takakuta K, Fujimori A, Chikanishi T, Tanokura A, Iwatsuki Y, Yamamoto M, Nakajima H, Okada M, Itoh H.
    Eur J Pharmacol; 2010 Mar 10; 629(1-3):118-24. PubMed ID: 20006961
    [Abstract] [Full Text] [Related]

  • 40. Captopril slows the progression of chronic renal disease in partially nephrectomized rats.
    Hall RL, Wilke WL, Fettman MJ.
    Toxicol Appl Pharmacol; 1985 Sep 30; 80(3):517-26. PubMed ID: 3898470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.